Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2026-06-03 16:55:06 ET · period of report 2026-06-02 · accession 0001213900-26-064792 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 16:55 | 2026-06-02 | TARA | CONKLING WILLIAM | Chief Commercial Off | F - Tax | $4.34 | -6,008 | 70.0K | -8% | -$26.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-02 | F | D | 6,008 | $4.34 | 69,992 | D | — | — | (F1) 1. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on June 2, 2025. |